SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica iito 600x60px

Persons > All

Find below all kinds of persons.

Total search results: 6675 | Ordered by Person (ascending)
next pagenext page 1 2 3 ... 59 60 61 ... 65 66 67  next pagenext page

order ascendingorder descendingPerson order ascendingorder descendingPosition order ascendingorder descendingOrganisation (Group) order ascendingorder descendingCountry
Trutnau, Hans-H. (Kinomics 200507) n. a. Kinomics GmbH Germany
Tryggvason, Kristian (BioLamina 201303 CEO) Chief Executive Officer (CEO) BioLamina (Group) Sweden
Tröndle, Norbert (Genaxxon BioScience 200512) n. a. Genaxxon BioScience GmbH Germany
Trösken, Volker (Amedo 201003 Managing Director) Managing Director Amedo Smart Tracking Solutions GmbH Germany
Tsao, Doris (Univ of Bremen 200610) n. a. University of Bremen Germany
Tscheppe, Michael (Nuvonis 201802 Managing Director + Co-Founder) Managing Director Nuvonis Technologies GmbH Austria
Tsybin, Yuri (EPFL 201005 Professor) Professor EPFL (Ecole Polytechnique Fédérale de Lausanne) Switzerland
Tuason, Nico (Fluidigm 201502 Senior Product Manager) Product Manager (personnel) Fluidigm (Group) United States (USA)
Tudorica, Joanne (Trophic Communications 201801 before MacDougall Biomedical Communications) Public Relations Manager / Investor Relations Manager Trophic Communications GmbH Germany
Tuffs, Annette (Helmholtz 201710 Head of Communications Dept at MDC) Public Relations Manager / Investor Relations Manager Helmholtz-Gemeinschaft (HGF) (Group) Germany
Tullman, Stephen (Ceptaris Therapeutics 201308 CEO) Chief Executive Officer (CEO) Johnson & Johnson (JnJ) (Group) United States (USA)
Tulstrup, Søren (Galenica 201408 CEO of Vifor Pharma before Shire + Santaris Pharma 2008–2012 CEO) Chief Executive Officer (CEO) Vifor Pharma (Group) Switzerland
Tur, Christelle (Debiopharm 201504 Communications Coordinator) Public Relations Manager / Investor Relations Manager Debiopharm (Group) Switzerland
Turgut, Kaya (Turgut Ilaç 201511 Board Chairman + Founder) Board member Turgut Ilaçlari A.S. Turkey
Turner, Jonathan David (XL Technology Group 2005– SVP BusDev before Boehringer Head Corp BusDev before AstraZeneca) Managing Director Caprotec Bioanalytics GmbH Germany
Turner, Nat (Flatiron Health 201802 CEO + Co-Founder) Chief Executive Officer (CEO) Roche (Group) United States (USA)
Turner, Rodney (Ayoxxa 201612– CEO before interim CEO + Supervisory Board Member before Life Technologies + Evotec) Chief Executive Officer (CEO) Ayoxxa (Group) Germany
Turner, Simon (Alacrita 201706) Consultant (economic/technology) Alacrita (Group) United Kingdom (GB)
Turner, Stephen (Steve) (Protea Biosciences 201002 CEO) Chief Executive Officer (CEO) Protea Biosciences (Group) United States (USA)
Tuschl, Thomas (Rockefeller Univ 200601) n. a. LGC (Group) Germany
Tynes, Thomas E. (MeVis 200709–201204 Exec Board Director Marketing + Sales before Invivo Corp RESIGNED 4/12) Chief Commercial Officer (CCO) Varian Medical Systems (Group) Germany
Türeci, Özlem (Ganymed 200811 CEO + CSO) Chief Executive Officer (CEO) Astellas (Group) Germany
Tysiak, Michael (Cytolon 201504– CEO before Biobase 200110– joined as CFO became Managing Director) Managing Director Cytolon AG Germany
Tzalis, Dimitrios (Talos Chemicals 201309 CEO + Founder) Chief Executive Officer (CEO) Taros Chemicals GmbH & Co. KG Germany
Tzouvalis, Plato (Acrongenomics 200704 President) n. a. Acrongenomics Inc. United Kingdom (GB)
Ubags, Frank (Cevec 201504– CEO before COO since 201409 before Coral BioNet + Scil Proteins + Kiadis + Rhein Biotech) Chief Operating Officer (COO) Cevec (Group) Germany
Udier Blagovic, Marina (NousCom 201609– COO before Versant Ventures + Novartis + McKinsey) Chief Operating Officer (COO) Nouscom (Group) Switzerland
Ueberschaar, Nico (Univ Jena 201806 Head of MS platform) Head Mass Spectrometry / NMR Laboratory (university / research institute) University of Jena (Friedrich-Schiller-Universität Jena) Germany
Ueda, Teruhisa (Shimadzu 201504– CEO before General Manager Analytical + Measuring Instruments division joined 1082) Chief Executive Officer (CEO) Shimadzu (Group) Japan
Ueffing, Marius (Helmholtz 201202 Head Research Unit Protein Science at Helmholtz-Zentrum München) Researcher (university / research institute) Helmholtz-Gemeinschaft (HGF) (Group) Germany
Uhl, Nikolaus (Weitnauer Rechtsanwälte 200809 Berlin) n. a. Weitnauer Rechtsanwälte Wirtschaftsprüfer Steuerberater Germany
Uhlmann, Karen (Omeicos Therapeutics GmbH 201312 Managing Director) Managing Director Omeicos (Group) Germany
Ulbrich, Claudia (Cardior Therapeutics 201705– CEO before T-Cell Europe GmbH 201205 Managing Director) Managing Director Cardior Pharmaceuticals GmbH Germany
Ullerich, Lars (GNA Biosolutions GmbH 201507 Managing Director) Managing Director GNA Biosolutions GmbH Germany
Ullmann, Dirk (Proteros Biostructures 200903– CSO before Evotec Service Division for 11 years) Chief Scientific Officer (CSO) / Chief Development Officer (CDO) Proteros (Group) Germany
Ullrich, Axel (Max Planck 201102 Director MPI for Biochemistry, Dept. of Molecular Biology) Professor Max Planck Society for the Advancement of Science Germany
Ullrich, Dirk (Axicorp 201105 Managing Director) Managing Director Biocon (Group) Germany
Ullrich, Matthias (Jabocs Univ 201207 Prof of Microbiology at School of Engineering and Science) Professor Jacobs University Bremen gGmbH (JUB) Germany
Ulmer, Thomas (Immatics 201804– CFO before Merck (DE) as CFO of Allergopharma business unit) Chief Financial Officer (CFO) Immatics (Group) Germany
Ulshöfer, Veit (Merck (DE) 201507 Director + Global Head of Research + Bioinformatics) President/Director/Head Business Group/Unit/Division Merck (DE) (Group) Germany
Ulyanova, Elena (Entelechon 201208 Business Development + Marketing Manager at PolyQuant GmbH) Business Development Manager / Strategy Manager PolyQuant GmbH Germany
Umaña, Pablo (GlycaArt 200810 CSO and Co-founder) Chief Scientific Officer (CSO) / Chief Development Officer (CDO) Roche (Group) Switzerland
Umbarger, Ken (Schauenburg 201509 VP Sales + Services Americas for Markes) Sales Manager / Marketing Manager Schauenburg (Group) United States (USA)
Ungeheuer, Udo (Schott 200603) n. a. Schott (Group) Germany
Unger, Hermann (United Nations 201011 Project Manager for Joint FAO/IAEA Programme) n. a. UN (United Nations) Austria
Ungerer, Martin (Corimmun 2006 Co-founder before Procorde) Company Founder Johnson & Johnson (JnJ) (Group) Germany
Unkelbach, Gerd (Fraunhofer 201311 Head of CBP in Leuna) n. a. Fraunhofer (Group) Germany
Unterrainer, Gertraud (ProBioGen 200710– CFO before Biovertis) Chief Financial Officer (CFO) Minapharm (Group) Germany
Uppenkamp, Reinhard (Menarini 201611 CEO of Berlin-Chemie) Chief Executive Officer (CEO) Menarini (Group) Germany
Urbas, Lidija (BIA Separations 201505 Marketing) Sales Manager / Marketing Manager BIA Separations GmbH Austria
Uschmann, Katrin (Thüringen (govt) 201512 Investment Manager at bm|t) Investment Manager Thuringia (govt region) Germany
Usoskin, Alexander (Bruker 201006 R&D Manager HTS at BEST) Research & Development Manager Bruker Corporation (Group) United States (USA)
Usui, Akira (Ray Life Sciences 2007– President + founder before Perlegen Japan + Roche Japan + Tanabe Seiyaku) President/Director/Head Business Group/Unit/Division Ray Life Sciences Inc. (RLS) Japan
Uth, Christina (Sulfotools GmbH 201603– Managing Director + Co-Founder) Managing Director Sulfotools GmbH Germany
Utiger, Lukas (Lonza 201208 COO of Lonza Bioscience STEPPED DOWN 2/13) Chief Operating Officer (COO) Lonza Group (Group) Switzerland
Utku, Nalân (CellAct Pharma 200707– Managing Director + co-founder before GenPat77 200608 CEO) Managing Director CellAct Pharma GmbH Germany
Vafa, Omid (TeneoBio 201706 CBO) Chief Business Officer (CBO) Teneobio Inc. United States (USA)
Vahrson, Wolfgang (Genedata 200910 before Microdiscovery 200501) n. a. Genedata (Group) Switzerland
Valdettaro, Sharon (Roche 201109 Roche Partnering) Business Development Manager / Strategy Manager Roche (Group) Switzerland
Valinder, Kerstin (Nycomed 200808 Executive VP Business Developm) Business Development Manager / Strategy Manager Takeda (Group) Switzerland
Valla, Svein (NTNT 2008 Professor) Professor NTNU (Norwegian University of Science and Technology) Norway
Valor, Santiago (Synlab 201603 CMO) Chief Medical Officer (CMO) Synlab (Group) Germany
Valtink, Peter (Gesundheitswirtschaft Nordwest 201105 Senior Project Manager) Business Development Manager / Strategy Manager Gesundheitswirtschaft Nordwest e. V. Germany
van Aken, Tom B. (Avantium 200602– CEO) Chief Executive Officer (CEO) Avantium (Group) Netherlands
van Alphen, Frits (Inositec 201801–CMO before Roche + Vifor Pharma + Novartis) Chief Medical Officer (CMO) Inositec AG Switzerland
Van Beneden, Patrick (GIMV 201306) Investment Manager Gimv (Group) Belgium
van Berkel, Patrick (Celtic Therapeutics 201207– SVP RnD of ADC Therapeutics before Genmab + Crucell + Pharming) Research & Development Manager Auven Therapeutics (Group) Switzerland
van Blitterswijk, Clemens (Life Sciences Partners 201412 Partner before Founder of Isotis OrthoBiologics) Partner (venture partner) Life Sciences Partners (LSP) Netherlands
van Camp, Wim (BASF 201310 Managing Director of CropDesign) Managing Director BASF (Group) Belgium
van Dam, Martin (pharm-analyt 201202) n. a. pharm-analyt Labor GmbH Austria
van de Griendt, Robbert (Forbion 201810 General Partner + Hear Investor Relations + Impact) General Partner (venture partner) Forbion Capital Partners (NL) Netherlands
van de Sande, André (Xendo 201102– CEO before Schering-Plough Netherlands before Organon) Chief Executive Officer (CEO) Xendo (Group) Netherlands
van de Stolpe, Onno (Galapagos 1999– CEO + Founder before IntroGene BV + Molecular Probes Europe BV) Chief Executive Officer (CEO) Galapagos (Group) Belgium
van de Winkel, Jan (Genmab 201106 CEO before CSO + Co-Founder before Medarex Europe) Chief Executive Officer (CEO) Genmab (Group) Denmark
Van den Berghe, Jan (Genohm 201503 Financial Director) Chief Financial Officer (CFO) Agilent (Group) Switzerland
Van den Brulle, Jan (Sloning BioTechnology 201004 Scientific Director R&D) Research & Development Manager MorphoSys (Group) Germany
van den Dool, Gerrit (SigmaAlrich 199901– Head European Sales) Sales Manager / Marketing Manager Merck (DE) (Group) United States (USA)
van den Hoven, Ton (SurgVision 201710 CEO) Chief Executive Officer (CEO) Bracco (Group) Netherlands
van der Broek, Lykele (Bayer 201012 COO Bayer CropScience before Bayer Animal Health 200610– division head) Chief Operating Officer (COO) Bayer (Group) Germany
Van der Geyten, Serge (JnJ 201501 Director for Neuroscience External Affairs at Janssen Pharmaceutica NV) Business Development Manager / Strategy Manager Johnson & Johnson (JnJ) (Group) Belgium
Van der Heide, Teun (Lonza 201303 Head Lonza Bioscience) President/Director/Head Business Group/Unit/Division Lonza Group (Group) Switzerland
van der Horst, Robert-Jan (Equinet Bank 201410 Research Analyst) Analyst (Financial / Industry) Equinet (Group) Germany
van der Knaap, Rob (Spark Holland 200804– President ) President/Director/Head Business Group/Unit/Division Spark Holland (Group) Netherlands
van der Meer, Edward (Healthy Aging Campus Netherlands 201410 Managing Director) Cluster Manager Healthy Ageing Campus Netherlands Netherlands
van der Veen, Lars (iOnctura 201706– COO before Solvay Pharma + Organon + Boehringer Ingelheim) Chief Operating Officer (COO) iOnctura S.A. Switzerland
van der Zande, Piet (Thermo Fisher 201006 Managing Director Thermo Fisher Scientific GmbH) Managing Director Thermo Fisher (Group) Germany
van Dessel, Vincent (Euronext 201511 CEO of Euronext Brussels) Chief Executive Officer (CEO) Euronext (Group) Belgium
van Deventer, Sander (Forbion 201204 General Partner) General Partner (venture partner) Forbion Capital Partners (NL) Netherlands
van Duijnhoven, Henk (Danaher 201409 SVP Dental Segment) President/Director/Head Business Group/Unit/Division Danaher (Group) United States (USA)
van Gool, Alain (Univ Nijmegen 201904 Prof + Head of CoE for Translational Omics) Professor University of Nijmegen (Radboud University) Netherlands
van Gorp, Jasper (Gilde Investment 201708 Managing Partner at Gilde Healthcare) Managing Partner Gilde Investment (Group) Netherlands
van Hagen, Paul (Xeltis 201602– CFO before Prosensa + Crucell + Ernst & Young) Chief Financial Officer (CFO) Xeltis (Group) Switzerland
van Hall, Andre (BioCampus Cologne 201307– Prokurist before BioMedizinZentrum Dortmund) n. a. BioCampus Cologne Management GmbH Germany
Van Hauwermeiren, Tim (Argen-X 201101 CEO before Ablynx BusDev Manager before P&G) Chief Executive Officer (CEO) Argenx (Argen-X) (Group) Netherlands
van Heekeren, Robbert (Kiadis Pharma 2008–201808 CFO LEFT 8/18) Chief Financial Officer (CFO) Kiadis (Group) Netherlands
van Hoeven, Kees (Netherlands (govt) 201405 RVO) Administrative Officer (personnel) Netherlands (govt) Netherlands
van Houten, François Adrianus (Frans) (Philips 201104– designated CEO before since 1986 at Philips) Chief Executive Officer (CEO) Philips (Group) Netherlands
van Husen, Georg (Boehringer Ingelheim 201804 SVP Therapeutic Area CardioMetabolism) President/Director/Head Business Group/Unit/Division Boehringer Ingelheim (Group) Germany
van Koppen, Chris J. (ElexoPharm 201201– Head of Research before Merck Sharp & Dohme NL) Chief Scientific Officer (CSO) / Chief Development Officer (CDO) ElexoPharm GmbH Germany
van Lent, Horst-Dieter (Omnibal 200906 Head Purchasing) Business Manager Omnilab (DE) (Group) Germany
next pagenext page 1 2 3 ... 59 60 61 ... 65 66 67  next pagenext page


Picture [LSUS] – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture EBD Group BioPharm America 2019 Boston September 600x60px

» top